opales, not to be argumentative, but he doesn't really seem to say why he doesn't think that smart drugs work, then he uses 2 examples, and i know right off the bat that one of them i have taken at a party before (ghb). if he is lumping that in with piracetam i don't see why i should even read that article
Well, he explicitly referred to smart drugs in a more wide sense, which was the reason GHB was included (for similar reasons say 5-htp is discussed in the noots sections here). Most likely GHB was more "hip" when the article was published 10years ago, as illustrated by the fact that the authors behind "Smart Drugs" and "Smart Drugs 2" also did a book called:
GHB: The Natural Mood Enhancer
by Ward Dean, M.D., John Morgenthaler and Steven Wm. Fowkes
Regarding why they don't work, it's more like that the evidence was them doing so is very weak/nonexistent, so there is no reason to assume that they would, especially given that they are psychoactive substances with unknown but likely interactions and possibly lethal consequences when used more recreationally.
Why he thinks they have not been proven to work is illustrated by this passage I already posted:
The efficacy of these drugs is most probably only marginal (if there is efficacy at all), in patients suffering from Alzheimer's disease and only few well controlled trials have been published using state of the art methodology13. Most of these drugs were evaluated in the 70s and 80s without proper neuropsychological tools, and only sparse positive information has been published. Most probably, many of the negative trials have not been published thus far, due to the publication bias for such trials. The efficacy of these drugs in patients is already debatable. The use of nootropics in healthy individuals as suggested on the Net has never been proven to be of any use. No double blind, placebo controlled trials in healthy volunteers of enough power have been published assessing the safety and efficacy of these drugs using modern, validated neuropsychological test batteries. The studies referred to on the Net by the smart drug advocates are mostly published in non peer-reviewed, obscure journals and in proceedings of congresses. The facts presented in those papers are over-interpreted by the advocates of smart drugs. Furthermore facts to support their use in man have been extrapolated from animal pharmacology without too much knowledge of the problems of many of the animal models used.
This sentence being in my view the important one (but not that the other one's do not contain also useful information)
No double blind, placebo controlled trials in healthy volunteers of enough power have been published assessing the safety and efficacy of these drugs using modern, validated neuropsychological test batteries.
That one sentence contains critique on multiple levels.
The parts on deprenyl and GHB were just to illustrate that these substances are not inherently benign but possibly very dangerous.
Can anyone get the two other commentaries I referred to in my previous post?
Note a few of other commentaries regarding this subject in the references. Could anyone get these, perhaps through their university subscription and provide them here? I am especially interested in these:
Baker LS "Smart drugs": a caution to everybody. Am J Psychiatry. 1996 Jun 1; 153(6): 844-845
Carson WH, Markowitz JS. "Smart drugs"? Ann Clin Psychiatry. 1996 Mar 1; 8(1): 41-42